Missing/wrong data?
Log in to edit
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
scientific article published on 08 March 2016
Author/s
author: Keith Flaherty, David Cella, George Wilding, Toni K Choueiri, Janice P Dutcher, Michael A. Carducci, Michael A.S. Jewett
Work details
Publication date
March 8, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.